The purpose of the company is to provide corporate consulting services to biotechnology and pharmaceutical companies in the areas of drug development, biomarkers, experimental medicine, and transport research, with a focus on neuroscience and rare diseases. Furthermore, the company offers services related to clinical trials, including their implementation, medical monitoring, and regulatory strategy, as well as the achievement of results. The company may establish branches and subsidiaries in Switzerland and abroad, participate in other companies, and conduct all business that is directly or indirectly related to its purpose. The company may acquire, encumber, sell, and manage real estate in Switzerland and abroad.